Literature DB >> 3587372

Potency of N6-modified N-alkyl adenosine-5'-uronamides at presynaptic adenosine receptors in guinea-pig ileum.

D M Paton, P A Lockwood, D L Martlew, R A Olsson.   

Abstract

The ability of a series of N6-modified N-alkyl-5'-uronamides to cause presynaptic inhibition of transmitter release was examined in isolated guinea-pig ileum stimulated at 0.2 Hz. These analogs inhibited the twitch responses to nerve stimulation, the majority being full agonists with their inhibitory effects being antagonised by theophylline. These analogs had no significant effects on responses of ileum to carbachol. N-ethyl 5'-uronamide substitution resulted in an up to four-fold reduction in activity of N6-substituted adenosine analogs, while stereoselectivity of the N6-substituted analogs continued to be present. 5'-Uronamide substitutions to N6-(3-pentyl)-adenosine resulted in a marked loss of activity when there were large alkyl groups at the amide or with amides of secondary amines. It was concluded that adenosine analogs interact with both the N6 and C-5' regions of the adenosine receptor in this tissue, with the interaction being less than additive.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3587372     DOI: 10.1007/BF00172801

Source DB:  PubMed          Journal:  Naunyn Schmiedebergs Arch Pharmacol        ISSN: 0028-1298            Impact factor:   3.000


  12 in total

Review 1.  Inhibitors of adenosine deaminase.

Authors:  R P Agarwal
Journal:  Pharmacol Ther       Date:  1982       Impact factor: 12.310

2.  Structure-activity relations for presynaptic inhibition of noradrenergic and cholinergic transmission by adenosine: evidence for action on A1 receptors.

Authors:  D M Paton
Journal:  J Auton Pharmacol       Date:  1981-09

3.  Modification of the 5' position of purine nucleosides. 2. Synthesis and some cardiovascular properties of adenosine-5'-(N-substituted)carboxamides.

Authors:  R N Prasad; D S Bariana; A Fung; M Savic; K Tietje; H H Stein; H Brondyk; R S Egan
Journal:  J Med Chem       Date:  1980-03       Impact factor: 7.446

4.  N6-substituted N-alkyladenosine-5'-uronamides: bifunctional ligands having recognition groups for A1 and A2 adenosine receptors.

Authors:  R A Olsson; S Kusachi; R D Thompson; D Ukena; W Padgett; J W Daly
Journal:  J Med Chem       Date:  1986-09       Impact factor: 7.446

5.  Dog coronary artery adenosine receptor: structure of the N6-aryl subregion.

Authors:  S Kusachi; R D Thompson; N Yamada; D T Daly; R A Olsson
Journal:  J Med Chem       Date:  1986-06       Impact factor: 7.446

6.  The effect of pH on interaction of nitrobenzylthioinosine and hydroxynitrobenzylthioinosine with the nucleoside transporter of human erythrocyte membranes.

Authors:  C E Cass; W P Gati; R Odegard; A R Paterson
Journal:  Mol Pharmacol       Date:  1985-06       Impact factor: 4.436

7.  Potency of N6-modified N-alkyl adenosine-5'-uronamides at presynaptic adenosine receptors in guinea-pig ileum.

Authors:  D M Paton; P A Lockwood; D L Martlew; R A Olsson
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1987-03       Impact factor: 3.000

8.  Binding of [3H]cyclohexyladenosine to adenosine recognition sites in guinea pig ileal membranes: comparison with binding in brain membranes.

Authors:  M Williams; H L Valentine
Journal:  Neurosci Lett       Date:  1985-06-04       Impact factor: 3.046

9.  Cardiovascular effects of nucleoside analogs.

Authors:  H H Stein; P Somani; R N Prasad
Journal:  Ann N Y Acad Sci       Date:  1975-08-08       Impact factor: 5.691

10.  Nature of the N6 region of the adenosine receptor in guinea-pig ileum and rat vas deferens.

Authors:  D M Paton; R A Olsson; R T Thompson
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1986-07       Impact factor: 3.000

View more
  1 in total

1.  Potency of N6-modified N-alkyl adenosine-5'-uronamides at presynaptic adenosine receptors in guinea-pig ileum.

Authors:  D M Paton; P A Lockwood; D L Martlew; R A Olsson
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1987-03       Impact factor: 3.000

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.